In Q2 fiscal 2026 (the quarter ended June 30, 2026), Ventas's largest business segment was Senior Housing Operating Portfolio (SHOP), with $1.36 billion or 79% of revenue, up 32.0% from a year earlier. Next: Outpatient Medical and Research Portfolio (13%) and Triple Net Leased Properties (7%).
By product or service, Outpatient Medical and Research Portfolio brought in 65% and Triple Net Leased Properties brought in 35% of revenue in Q2 fiscal 2026.
By country, United States brought in 89%, Canada brought in 11% and United Kingdom brought in 1% of revenue in Q1 fiscal 2024.
The fastest-growing business segment from a year earlier was Senior Housing Operating Portfolio (SHOP) (+32.0%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Senior Housing Operating Portfolio (SHOP) | $1.4B | $1.3B | $1.1B | $1.0B | 79% |
| Outpatient Medical and Research Portfolio | $229.3M | $230.9M | $226.9M | $221.5M | 13% |
| Triple Net Leased Properties | $124.9M | $123.1M | $160.1M | $152.7M | 7% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Outpatient Medical and Research Portfolio | $228.6M | $230.1M | $226.2M | $220.8M | 65% |
| Triple Net Leased Properties | $124.9M | $123.1M | $160.1M | $152.7M | 35% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Country | Q1 FY24 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Share |
|---|---|---|---|---|---|
| United States | $1.1B | $1.0B | $983.7M | $958.1M | 89% |
| Canada | $129.0M | $116.9M | $115.3M | $112.1M | 11% |
| United Kingdom | $7.6M | $7.4M | $7.3M | $7.0M | 1% |
In USD, fiscal quarters as reported; share = part of Q1 FY24 revenue.
Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio and Triple Net Leased Properties (as reported for Q2 fiscal 2026).
Senior Housing Operating Portfolio (SHOP): $1.36 billion, or 79% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Outpatient Medical and Research Portfolio (65%) and Triple Net Leased Properties (35%).
By country in Q1 fiscal 2024: United States (89%), Canada (11%) and United Kingdom (1%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Senior Housing Operating Portfolio (SHOP) | USD 1.36B | 79.4% |
| Outpatient Medical and Research Portfolio | USD 229.31M | 13.4% |
| Triple Net Leased Properties | USD 124.86M | 7.3% |
| Corporate and otheri | USD 11.95M |
Sum of items USD 1.72B; corporate items and eliminations USD 11.95M. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q1 FY22 | Q4 FY21 | Q3 FY21 | Q2 FY21 | Q1 FY21 | Q4 FY20 | Q3 FY20 | Q2 FY20 | Q1 FY20 | Q4 FY19 | Q3 FY19 | Q2 FY19 | Q1 FY19 | Q4 FY18 | Q3 FY18 | Q2 FY18 | Q1 FY18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senior Living Operations | – | – | – | – | – | – | – | – | – | – | 775.2M | – | – | – | 674.1M | 668.6M | 658.1M | 651.1M | 647.4M | 558.0M | 536.0M | 528.6M | 529.7M | 541.3M | 549.3M | 576.8M | 568.3M | 541.1M | 520.7M | 521.4M | 517.2M | 518.6M | 519.0M | 514.8M |
| Senior Housing Operating Portfolio (SHOP) | 1.4B | 1.3B | – | 1.1B | 1.0B | 968.9M | – | 845.5M | 817.6M | 813.3M | – | 754.4M | 724.6M | 705.0M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Triple Net Leased Properties | 124.9M | 123.1M | – | 160.1M | 152.7M | 156.1M | – | 155.3M | 153.9M | 155.4M | 155.3M | 159.8M | 154.4M | 149.7M | 147.1M | 150.1M | 149.4M | 151.6M | 153.3M | 181.4M | 159.2M | 159.9M | 168.0M | 156.1M | 176.2M | 194.9M | 191.1M | 193.4M | 196.4M | 200.1M | 189.2M | 190.3M | 169.0M | 191.8M |
| Office operations | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 201.1M | – | – | 201.2M | 195.4M | 204.5M | 202.9M | 199.8M | 201.7M | 200.8M | 195.2M | 210.6M | 212.5M | 217.0M | 204.0M | 203.2M | 197.3M | 196.1M | 194.4M | 195.8M |
| Outpatient Medical and Research Portfolio | 229.3M | 230.9M | – | 226.9M | 221.5M | 222.0M | – | 221.6M | 219.6M | 219.5M | 222.7M | 227.0M | 216.4M | 203.6M | – | 201.4M | 199.9M | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Corporate and other | 11.9M | 10.2M | – | 13.5M | 14.0M | 11.1M | – | 13.9M | 9.9M | 11.7M | 11.2M | 8.6M | 11.0M | 18.9M | 29.1M | 17.2M | 15.6M | 13.7M | 26.3M | 32.1M | 21.1M | 22.0M | 21.7M | 20.7M | 22.4M | 29.9M | 24.2M | 31.7M | 29.6M | 18.2M | 19.6M | 31.6M | 59.9M | 41.4M |